A Randomized, Double-Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical Epidermal Growth Factor for the Treatment of Melasma.

CONCLUSIONS: This study suggests that topical EGF is a safe, noninvasive, and effective treatment for melasma. J Drugs Dermatol. 2018;17(6):970-973.
PMID: 30235384 [PubMed - in process]

Source: Journal of Drugs in Dermatology - September 21, 2018 Category: Dermatology Tags: J Drugs Dermatol Source Type: research